Donor Screening for Human T‐Cell Lymphotrophic Virus 1/2: The future Is Uncertain

Screening of organ donors for HTLV‐1/2 infection has advantages and disadvantages that must be weighed, and rational decisions will require new evidence. See minireview by Kaul et al on page 207.

Saved in:

Bibliographic Details
Published in:	American journal of transplantation Vol. 10; no. 2; pp. 199 - 200
Main Author:	Humar, A.
Format:	Journal Article
Language:	English
Published:	Malden, USA Blackwell Publishing Inc 01-02-2010
Subjects:	HTLV-I Infections - diagnosis Human T-lymphotropic virus 1 - isolation & purification Humans T-Lymphocytes
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Screening of organ donors for HTLV‐1/2 infection has advantages and disadvantages that must be weighed, and rational decisions will require new evidence. See minireview by Kaul et al on page 207.
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Editorial-2 ObjectType-Commentary-1
ISSN:	1600-6135 1600-6143
DOI:	10.1111/j.1600-6143.2009.02970.x